A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies.
Li EW, Jones E, Bryant C, King T, Talaulikar D, Ng JY, Bryant A, Ridha Z, Doo NW, Menzies A, Ling S, Ho SJ, Abadir E, Vanguru V, Joshua D, Ho PJ.
Li EW, et al. Among authors: ng jy.
Eur J Haematol. 2024 Oct;113(4):521-529. doi: 10.1111/ejh.14266. Epub 2024 Jul 2.
Eur J Haematol. 2024.
PMID: 38956924